%0 Journal Article %T Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors %A Achhal El Kadmiri, Mohammed Amine %A Rajan, Arun %J Mediastinum %D 2018 %B 2018 %9 %! Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors %K %X Thymic epithelial tumors (TETs) are a family of rare cancers that exhibit diverse histology and variable clinical behavior. The prognosis associated with TETs, especially thymomas, is generally good relative to other solid tumors with 5-year survival rates of 67% to 93% in patients with locally advanced disease that can be completely resected (1). %U https://med.amegroups.org/article/view/4267 %V 2 %P %@ 2522-6711